Grace Therapeutics growth metrics data for the quarter ended Jun 2026. These growth metrics cover 26 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Sep2019 | Dec2019 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth Ratios | ||||||||||||||||||||||||||
| EBITDA Margin (QoQ) | ||||||||||||||||||||||||||
| EBIT Margin (QoQ) | ||||||||||||||||||||||||||
| EBT Margin (QoQ) | ||||||||||||||||||||||||||
| FCF Margin (QoQ) | ||||||||||||||||||||||||||
| Gross Margin (QoQ) | ||||||||||||||||||||||||||
| Interest Coverage Ratio (QoQ)Interest Cover (QoQ) | ||||||||||||||||||||||||||
| Net Margin (QoQ) | ||||||||||||||||||||||||||
| Operating Margin (QoQ) | ||||||||||||||||||||||||||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | 13,657.00 | 8,435.00 | 2,890.00 | 1,782.00 | -515.00 | -570.00 | -3266.00 | -4237.00 | -3545.00 | -3203.00 | 2,347.00 | 3,529.00 | 3,233.00 | 2,560.00 | 116.00 | -29.00 | 387.00 | 1,029.00 | 327.00 | -1960.00 | ||||||
| Return on Assets [ROA] Growth (3y)ROA Growth (3y) | 6,354.00 | 9,597.00 | 4,663.00 | 1,971.00 | 1,074.00 | -827.00 | -1213.00 | -803.00 | -737.00 | 74.00 | 387.00 | 2,789.00 | 1,541.00 | |||||||||||||
| Return on Assets [ROA] Growth (5y)ROA Growth (5y) | 9,855.00 | 13,216.00 | 8,252.00 | 2,413.00 | -915.00 | |||||||||||||||||||||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | 1,794.00 | 4.00 | 69.00 | -84.00 | -503.00 | -51.00 | -2627.00 | -1056.00 | 189.00 | 291.00 | 2,923.00 | 126.00 | -107.00 | -382.00 | 478.00 | -18.00 | 308.00 | 261.00 | -225.00 | -2305.00 | ||||||
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | 17,271.00 | 9,043.00 | 2,346.00 | 1,217.00 | -290.00 | -420.00 | -4197.00 | -5605.00 | -5012.00 | -4717.00 | 3,757.00 | 5,061.00 | 4,101.00 | 3,585.00 | -820.00 | -220.00 | 614.00 | 1,035.00 | 886.00 | -2026.00 | ||||||
| Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y) | 8,805.00 | 11,969.00 | 3,906.00 | 1,906.00 | 674.00 | -1201.00 | -1552.00 | -1260.00 | -764.00 | -297.00 | -97.00 | 3,823.00 | 2,815.00 | |||||||||||||
| Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y) | 13,647.00 | 16,684.00 | 8,526.00 | 1,972.00 | -1573.00 | |||||||||||||||||||||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | 1,331.00 | 100.00 | -137.00 | -76.00 | -176.00 | -30.00 | -3915.00 | -1484.00 | 417.00 | 264.00 | 4,560.00 | -180.00 | -543.00 | -251.00 | 155.00 | 420.00 | 291.00 | 170.00 | 5.00 | -2492.00 | ||||||
| Return on Sales [ROS] Growth (1y)ROS Growth (1y) | -595357.00 | |||||||||||||||||||||||||
| Return on Sales [ROS] (QoQ)ROS (QoQ) |